Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

YOU WONT BELIEVE: Ikena oncology s return on capital employed insights - What They Never Told You

Ikena Oncology (NASDAQ:IKNA) brought in sales totaling $3.38 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 702.04%, resulting in a loss of $16.84 million. Ikena Oncology reached earnings of $2.80 million and sales of $20.22 million in Q4.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.